When was PERSIST.AI founded?

PERSIST.AI was founded in 2022 and raised its 1st funding round 1 year after it was founded.

Where is PERSIST.AI located?

PERSIST.AI is headquartered in Woodland, United States.

Who is the current CEO of PERSIST.AI?

Karthik Raman of PERSIST.AI. They have also founded 1 company.

How many employees does PERSIST.AI have?

As of Jul 31, 2026, the latest employee count at PERSIST.AI is 34.

Is PERSIST.AI a funded company?

PERSIST.AI is a funded company, having raised a total of $16.7M across 3 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on 2023.

When was the latest funding round of PERSIST.AI?

PERSIST.AI's latest funding was a $***** Series A round on May 19, 2025, with participation from 13 investors.

Where does PERSIST.AI rank among its competitors?

PERSIST.AI ranks 22nd amongst 878 active competitors, of which 28 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was PERSIST.AI, which secured $12M in May, 2025.

Who are the top competitors of PERSIST.AI?

PERSIST.AI's top competitors include Jubilant Life Sciences, Akums and Nivagen Pharmaceuticals. Among them, PERSIST.AI secured the most recent funding round in May, 2025.

PERSIST.AI - 2026 Company Profile, Team, Funding & Competitors

Company Details

Website: www.persist-ai.com/
Email ID: *****@persist-ai.com
Phone Number: +1 **********

Key Metrics

Founded Year

2022

Location

Woodland, United States

Stage

Series A

Total Funding

$16.7M in 3 rounds

Latest Funding Round

Series A, May 19, 2025, $*****

Investors

Spero Ventures & 14 more

Ranked

22^nd among 878 active competitors

Employee Count

34 as on Jul 31, 2026

Similar Companies

Jubilant Life Sciences & 1089 more

View PERSIST.AI's full profile

PERSIST.AI has raised a total funding of $16.7M over 3 rounds. Its first funding round was on 2023. Its latest funding round was a Series A round on May 19, 2025 for $*****. 13 investors participated in its latest round. PERSIST.AI has 15 institutional investors.

Here is the list of recent funding rounds of PERSIST.AI:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 19, 2025	6295326	Series A	4193921	7213261	7905110	3165132
May 08, 2023	7246095	Seed	1914339	8385716	6190410	Fellows Fund & 3 more
2023	2530	Seed	8567	5796	9358	Y Combinator

Access funding benchmarks and valuations. Sign up today!

View details of PERSIST.AI's funding rounds and investors

The founders of PERSIST.AI are Karthik Raman and Christopher Shelner. Karthik Raman is the CEO of PERSIST.AI.

Here are the details of PERSIST.AI's key team members:

Karthik Raman: Co-Founder & CEO of PERSIST.AI.
Contact Info: 1 email address
Christopher Shelner: Co-Founder & COO of PERSIST.AI.
Contact Info: 1 email address

View details of PERSIST.AI's Founder profiles and Board Members

PERSIST.AI's employee count trend

PERSIST.AI has 34 employees as of Jul 26. Here is PERSIST.AI's employee count trend over the years:

Uncover PERSIST.AI's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of PERSIST.AI include Jubilant Life Sciences, Akums and Nivagen Pharmaceuticals. Here is the list of Top 10 competitors of PERSIST.AI, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Jubilant Life Sciences 1978, Noida (India), Public	Company offering a suite of R&D and manufacturing services for small molecules and generics	-	Samena Capital, General Atlantic & 1 others	59/100
2nd	Akums 2004, Delhi (India), Public	CDMO focusing on spectrum of dosage forms and therapeutic segments	$70M	Quadria Capital & 5 others	58/100
3rd	Nivagen Pharmaceuticals 2009, Sacramento (United States), Acquired	Developer and contract manufacturer of generic drugs, tablets, capsules, ointment and solution	$31M	Telegraph Hill Partners, BizCap & 1 others	57/100
4th	Nectar Lifesciences 1995, Chandigarh (India), Public	Manufacturer of cephalosporin APIs and generic formulations	$46.9M	Vedanta Capital, NSR Partners & 1 others	55/100
5th	Recipharm 1995, Jordbro (Sweden), Acquired	Contract services for pharmaceutical development and manufacturing	-	Ampersand Capital, CPP Investments	54/100
6th	Supriya Lifescience 2008, Mumbai (India), Public	Manufacturer of active pharmaceutical ingredients and finished dosage formulations for healthcare	-	-	54/100
7th	Labiana 1958, Corbera de Llobregat (Spain), Unfunded	Contract laboratory and contract manufacturing services for pharmaceutical and animal health industries	-	-	54/100
8th	Chugai Pharmaceutical 1925, Tokyo (Japan), Acquired	Developer of innovative pharmaceutical products and services	-	Digital Pharma Lab	54/100
9th	Asahi Kasei 1931, Chiyoda-ku (Japan), Public	CDMO focused on manufacturing of liquid, solid & injectable drug formulations	-	Europa	53/100
10th	Pontika Aerotech 2017, Paonta Sahib (India), Series A	Contract manufacturer of formulations	$11.9M	India SME Investments, Vidit Healthcare & 14 others	52/100
22nd	PERSIST.AI 2022, Woodland (United States), Series A	CDMO focused on manufacturing formulations for biopharma sectors	$16.7M	Spero Ventures, SignalFire & 13 others	48/100